<DOC>
	<DOC>NCT00231244</DOC>
	<brief_summary>The objective of this study is to allow treatment with the sirolimus-eluting Bx VELOCITYTM stent in patients with a serious disease or condition for which there is no generally acceptable alternate treatment available.</brief_summary>
	<brief_title>Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1. Male or nonpregnant female patient minimum 18 years of age 2. There is no alternative treatment for this patient as determined by the treating physician and an uninvolved cardiac surgeon; 3. Target lesion is 2.50mm and 3.50mm in diameter (visual estimate); 4. Target lesion is 45mm in length (visual estimate), treated with a maximum of three 18 mm stents; 1. There is currently another method of treatment for the patient, including coronary artery bypass surgery (CABG) or brachytherapy; 2. The study target lesion has definite or possible thrombus present by angiographic criteria.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>